S&P 500   4,245.01 (-0.67%)
DOW   33,357.90 (-0.78%)
QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.37 (-0.48%)
BABA   85.67 (-0.28%)
AMD   97.00 (+1.08%)
T   14.83 (-1.26%)
F   12.30 (-1.05%)
MU   67.07 (-1.28%)
CGC   0.87 (-5.67%)
GE   110.44 (+0.46%)
DIS   79.39 (-0.82%)
AMC   7.69 (-2.78%)
PFE   32.03 (-1.14%)
PYPL   56.87 (-3.50%)
NFLX   376.94 (-0.61%)
S&P 500   4,245.01 (-0.67%)
DOW   33,357.90 (-0.78%)
QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.37 (-0.48%)
BABA   85.67 (-0.28%)
AMD   97.00 (+1.08%)
T   14.83 (-1.26%)
F   12.30 (-1.05%)
MU   67.07 (-1.28%)
CGC   0.87 (-5.67%)
GE   110.44 (+0.46%)
DIS   79.39 (-0.82%)
AMC   7.69 (-2.78%)
PFE   32.03 (-1.14%)
PYPL   56.87 (-3.50%)
NFLX   376.94 (-0.61%)
S&P 500   4,245.01 (-0.67%)
DOW   33,357.90 (-0.78%)
QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.37 (-0.48%)
BABA   85.67 (-0.28%)
AMD   97.00 (+1.08%)
T   14.83 (-1.26%)
F   12.30 (-1.05%)
MU   67.07 (-1.28%)
CGC   0.87 (-5.67%)
GE   110.44 (+0.46%)
DIS   79.39 (-0.82%)
AMC   7.69 (-2.78%)
PFE   32.03 (-1.14%)
PYPL   56.87 (-3.50%)
NFLX   376.94 (-0.61%)
S&P 500   4,245.01 (-0.67%)
DOW   33,357.90 (-0.78%)
QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.37 (-0.48%)
BABA   85.67 (-0.28%)
AMD   97.00 (+1.08%)
T   14.83 (-1.26%)
F   12.30 (-1.05%)
MU   67.07 (-1.28%)
CGC   0.87 (-5.67%)
GE   110.44 (+0.46%)
DIS   79.39 (-0.82%)
AMC   7.69 (-2.78%)
PFE   32.03 (-1.14%)
PYPL   56.87 (-3.50%)
NFLX   376.94 (-0.61%)
NASDAQ:NRC

National Research (NRC) Stock Forecast, Price & News

$44.61
-0.73 (-1.61%)
(As of 01:47 PM ET)
Compare
Today's Range
$44.61
$45.65
50-Day Range
$41.80
$46.78
52-Week Range
$34.69
$47.60
Volume
7,406 shs
Average Volume
35,849 shs
Market Capitalization
$1.10 billion
P/E Ratio
38.13
Dividend Yield
1.08%
Price Target
N/A

National Research MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
1.89% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.75mentions of National Research in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.40 out of 5 stars

Business Services Sector

241st out of 317 stocks

Commercial Physical Research Industry

13th out of 14 stocks


NRC stock logo

About National Research (NASDAQ:NRC) Stock

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

NRC Price History

NRC Stock News Headlines

Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
National Research (NASDAQ:NRC) Shares Gap Down to $46.15
National Research Corporation Declares Special Dividend
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
National Research (NASDAQ: NRC)
See More Headlines
Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

NRC Company Calendar

Last Earnings
8/01/2023
Ex-Dividend for 9/22 Dividend
9/15/2023
Dividend Payable
9/22/2023
Today
9/27/2023
Ex-Dividend for 10/13 Dividend
9/28/2023
Dividend Payable
10/13/2023
Next Earnings (Estimated)
11/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:NRC
Employees
491
Year Founded
1981

Profitability

Net Income
$31.80 million
Pretax Margin
26.11%

Debt

Sales & Book Value

Annual Sales
$151.57 million
Cash Flow
$1.46 per share
Book Value
$2.92 per share

Miscellaneous

Free Float
23,978,000
Market Cap
$1.10 billion
Optionable
Not Optionable
Beta
0.48

Social Links

The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Michael D. Hays (Age 68)
    Founder, CEO, Pres & Director
    Comp: $131.65k
  • Mr. Kevin R. Karas C.P.A. (Age 65)
    CPA, Sr. VP of Fin., CFO, Treasurer & Sec.
    Comp: $292.81k
  • Ms. Jona S. Raasch (Age 64)
    Chief Operating Officer
    Comp: $308.01k
  • Ms. Helen L. Hrdy (Age 58)
    Chief Growth Officer
    Comp: $291.31k
  • Mr. Jon Boumstein
    Chief Delivery Officer
  • Dr. Gregory Makoul M.S.
    Ph.D., Chief Transformation Officer
  • Linda Stacy
    VP of Fin.
  • Megan Charko
    Sr. Mang. of Content Marketing













NRC Stock - Frequently Asked Questions

How have NRC shares performed in 2023?

National Research's stock was trading at $37.30 at the beginning of 2023. Since then, NRC shares have increased by 19.6% and is now trading at $44.62.
View the best growth stocks for 2023 here
.

Are investors shorting National Research?

National Research saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 271,900 shares, an increase of 163.2% from the August 31st total of 103,300 shares. Based on an average daily volume of 27,900 shares, the short-interest ratio is currently 9.7 days. Currently, 1.9% of the shares of the company are short sold.
View National Research's Short Interest
.

When is National Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our NRC earnings forecast
.

How were National Research's earnings last quarter?

National Research Co. (NASDAQ:NRC) announced its quarterly earnings results on Tuesday, August, 1st. The company reported $0.29 EPS for the quarter. The firm had revenue of $36.16 million for the quarter. National Research had a net margin of 19.65% and a trailing twelve-month return on equity of 39.94%.

How often does National Research pay dividends? What is the dividend yield for National Research?

National Research announced a None dividend on Wednesday, September 6th. Investors of record on Monday, September 18th will be paid a dividend of $1.00 per share on Friday, September 22nd. The ex-dividend date is Friday, September 15th.
Read our dividend analysis for NRC
.

What ETF holds National Research's stock ?

Small Cap US Equity Select ETF holds 16,946 shares of NRC stock, representing 2.76% of its portfolio.

Is National Research a good dividend stock?

National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.04%. The dividend payout ratio is 41.03%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NRC.

What is Michael D. Hays' approval rating as National Research's CEO?

85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees.

What other stocks do shareholders of National Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD).

What is National Research's stock symbol?

National Research trades on the NASDAQ under the ticker symbol "NRC."

Who are National Research's major shareholders?

National Research's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (13.04%), BlackRock Inc. (4.38%), Conestoga Capital Advisors LLC (2.97%), QV Investors Inc. (1.83%), Renaissance Technologies LLC (1.50%) and State Street Corp (1.34%). Insiders that own company stock include Amandla Mk Trust, Joann M Martin, Jona S Raasch and Kevin R Karas.
View institutional ownership trends
.

How do I buy shares of National Research?

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Research's stock price today?

One share of NRC stock can currently be purchased for approximately $44.62.

How much money does National Research make?

National Research (NASDAQ:NRC) has a market capitalization of $1.10 billion and generates $151.57 million in revenue each year. The company earns $31.80 million in net income (profit) each year or $1.17 on an earnings per share basis.

How many employees does National Research have?

The company employs 491 workers across the globe.

Does National Research have any subsidiaries?
The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.
Read More
How can I contact National Research?

National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The official website for the company is www.nrchealth.com. The company can be reached via phone at (402) 475-2525 or via fax at 402-475-9061.

This page (NASDAQ:NRC) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -